RFP | August 20, 2010
National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics (DCEG), Genetic Epidemiology Branch (GEB) announces the availability of funding for plans to procure on a sole source basis with Retinoblastoma Solutions for services regarding Mutation Testing of RBI in Individuals from a Retinoblastoma Cohort. The contractor shall provide high quality mutation testing for highly characterized individuals with retinoblastoma and second tumors . . .